1. Correia L.L., Lebedev T.Yu., Efremova O.A., Proschaev K.I., Litovchenko E.S. The problem of polymorbidity with a combination of chronic obstructive pulmonary disease and certain cardiovascular diseases. Scientifc statements of Belgorod State University. Series: Medicine. Pharmacy. 2013;4 (147):12–7.
2. Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Boldueva S.A. et al. Comorbidities in practice. Clinical guidelines. Cardiovascular therapy and prevention. 2017;16 (6):5–56.. DOI: 10.15829/1728-8800-2017-6-5-56
3. Rushton CA, Satchithananda DK, Jones PW, Kadam UT. Noncardiovascular comorbidity, severity and prognosis in non-selectedheart failure populations: A systematic review and meta-analysis.International Journal of Cardiology. 2015; 196:98–106. DOI: 10.1016/j.ijcard.2015.05.180
4. Canepa M, Temporelli PL, Rossi A, Rossi A, Gonzini L, Nicolosi GL et al. Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial. Cardiology. 2017;136(2):128–37. DOI: 10.1159/000448166
5. Chen W, Tomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. The Lancet Respiratory Medicine. 2015;3(8):631–9. DOI: 10.1016/S2213-2600(15)00241-6
6. Ruten FH, Cramer M-JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J-WJ et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. European Heart Journal. 2005;26(18):1887–94. DOI: 10.1093/eurheartj/ehi291
7. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. The Lancet. 2007;370(9589):765–73. DOI: 10.1016/S0140-6736(07)61380-4
8. Ruten FH. β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease. Archives of Internal Medicine. 2010;170(10):880–7. DOI: 10.1001/archinternmed.2010.112
9. Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). European Journal of Heart Failure. 2009;11(3):292–8. DOI: 10.1093/eurjhf/hfp001
10. O’Kelly N. Short-term outcomes in heart failure patients with chronic obstructive pulmonary disease in the community. World Journal of Cardiology. 2012;4(3):66–71. DOI: 10.4330/wjc.v4.i3.66
11. Plesner LL, Dalsgaard M, Schou M, Køber L, Vestbo J, Kjøller E et al. The prognostic signifcance of lung function in stable heart failure outpatients. Clinical Cardiology. 2017;40(11):1145–51. DOI: 10.1002/clc.22802
12. Hawkins NM. Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care: Editorial comment. European Journal of Heart Failure. 2018;20(1):111–3. DOI: 10.1002/ejhf.986
13. Honda Y, Watanabe T, Otaki Y, Tamura H, Nishiyama S, Takahashi H et al. Impact of reduced forced expiratory volume on cardiac prognosis in patients with chronic heart failure. Heart and Vessels. 2018;33(9):1037–45. DOI: 10.1007/s00380-018-1153-1
14. Ardashev A.V., Shlyakhto E.V., Arutiunov G.P., Belenkov Yu.N. National guidelines for risk identifcation and prevention of sudden cardiac death. Clinical Practice. 2012;4 (12):1–77.
15. Mareev V.Yu., Ageev F.T., Arutiunov G.P., Koroteev A.V., Revishvili A.Sh., Belenkov Yu.N. et al. National recommendations of VNOK and SSHF on the diagnostics and treatment of chronic heart failure (third review) Approved by OSSN Conference, December 15, 2009. Russian Heart Failure Journal. 2010;11 (1):3–62.
16. Chuchalin A.G., Aisanov Z.R., Chikina S.Yu., Chernyak A.V., Kalmanova E.N. Federal clinical recommendations of the Russian respiratory society on the use of spirometry. Pulmonology. 2014;6:11–24.
17. Braga JR, Tu JV, Austin PC, Sutradhar R, Ross HJ, Lee DS. Recurrent events analysis for examination of hospitalizations in heart failure: insights from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) trial. European Heart Journal - Quality of Care and Clinical Outcomes. 2018;4(1):18–26. DOI: 10.1093/ehjqcco/qcx015
18. Karoli N.A., Borodkin A.V., Rebrov A.P. Different origins of chronic heart failure in patients with chronic obstructive pulmonary disease. Pulmonology. 2016;26 (1):38–45.. DOI: 10.18093/08690189-2016-26-1-38-45
19. Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C et al. Chronic obstructive pulmonary disease in patients admited with heart failure. Journal of Internal Medicine. 2008;264(4):361–9. DOI: 10.1111/j.1365-2796.2008.01975.x
20. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR et al. Noncardiac Comorbidities in Heart Failure with Reduced Versus Preserved Ejection Fraction. Journal of the American College of Cardiology. 2014;64(21):2281–93. DOI: 10.1016/j.jacc.2014.08.036
21. Valk M, Broekhuizen B, Mosterd A, Zuithoff NPA, Hoes A, Ruten F. COPD in patients with stable heart failure in the primary care setting. International Journal of Chronic Obstructive Pulmonary Disease. 2015;10:1219–24. DOI: 10.2147/COPD.S77085
22. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M et al. Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD. Chest. 2010;138(1):32–8. DOI: 10.1378/chest.09-2810
23. Koziolova N.A., Masalkina O.V., Kozlova E.V. Regularities in development of chronic heart failure in patients with ischemic heart disease and chronic obstructive pulmonary disease associated with multiple comorbidity. Russian Heart Failure Journal. 2016;17(3):151–63.. DOI: 10.18087/rhf.2016.3.2222
24. Dalsgaard M, Plesner LL, Schou M, Kjøller E, Vestbo J, Iversen K. Prevalence of airflow obstruction in patients with stable systolic heart failure. BMC Pulmonary Medicine. 2017;17(1):6. DOI: 10.1186/s12890-016-0351-9
25. Khaletskaya A. I., Kuznetsov A. N., Shcherbinina E. V., Fomin I.V. Peculiarities of comorbid course of chronic obstructive pulmonary disease and chronic cardiac insufciency and their influence on patients life quality. Medical Almanac. 2017;3 (48):206–10.
26. Karas’kov A. M., Kamenskaya O.V., Klinkova A.S., Cherniavsky A.M. Chronic heart failure and external respiratory function in patients with ischemic heart disease. Russian Heart Failure Journal. 2014;15 (2):90–4.
27. Polyakov D.S., Fomin I.V., Valikulova F.Yu., Vaisberg A.R., Kraiem N., Badin Yu.V. et al. The EPOCH-CHF epidemiological program: decompensated chronic heart failure in real-life clinical practice (EPOCH-D–CHF). Russian Heart Failure Journal. 2016;17 (5):299–305.. DOI: 10.18087/rhf.2016.5.2239
28. Canepa M, Straburzynska-Migaj E, Drozdz J, Fernandez-Vivancos C, Pinilla JMG, Nyolczas N et al. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry: Chronic obstructive pulmonary disease in heart failure. European Journal of Heart Failure. 2018;20(1):100–10. DOI: 10.1002/ejhf.964
29. Sitnikova M.Yu., Lelyavina T.A., Fedotov P.A., Trukshina M.A., Dorofeikov V.V., Shlyakhto E.V. Risk stratifcation in ambulatory patients with heart failure and chronic obstructive pulmonary disease: evaluation of predictive value of standard prognostic markers for 5-years survival. Arterial Hypertension. 2009;15 (2):132–7.
30. Prokopova L.V., Kashuba S.M., Galenko V.L., Fedotov P.A., Smirnov B.I., Sitnikova M.Yu. Role of simple clinico-laboratory parameters in oneyear prediction of lEF HF course in the epoch of high-tech methods of health care: the available prognosis study. Russian Heart Failure Journal. 2015;16 (3):137–44.
31. Eriksson B, Wändell P, Dahlström U, Näsman P, Lund LH, Edner M. Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics. Scandinavian Journal of Primary Health Care. 2018;36(2):207–15. DOI: 10.1080/02813432.2018.1459654